YAP1 and pancreatic ductal adenocarcinoma: Modeling KRAS-dependent pancreatic ductal adenocarcinomas leads to the identification of a secretory program including COX2, MMP7, IL-6, and IL-1α, which is supported by YAP, along with the canonical YAP/TAZ targets CTGF and CYR61.